These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 23780894

  • 21. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Hu Z, Hu X, Long J, Su L, Wei B.
    Gene; 2013 Oct 10; 528(2):67-73. PubMed ID: 23872202
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. XRCC1 Arg399Gln polymorphism is not associated with breast cancer in Chinese.
    Guo S, Mao X, Ming L.
    Int J Clin Exp Med; 2015 Oct 10; 8(7):10429-36. PubMed ID: 26379833
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
    Li Y, Liu F, Tan SQ, Wang Y, Li SW.
    PLoS One; 2012 Oct 10; 7(9):e44441. PubMed ID: 22984511
    [Abstract] [Full Text] [Related]

  • 26. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
    Dong LM, Zhang XY, Teng H, Li MS, Wang P.
    Genet Mol Res; 2014 Nov 28; 13(4):9976-85. PubMed ID: 25501209
    [Abstract] [Full Text] [Related]

  • 27. Gene polymorphism of XRCC1 Arg399Gln and cervical carcinoma susceptibility in Asians: a meta-analysis based on 1,759 cases and 2,497 controls.
    Liu YT, Shi JP, Fu LY, Zhou B, Wang HL, Wu XM.
    Asian Pac J Cancer Prev; 2013 Nov 28; 14(1):189-93. PubMed ID: 23534722
    [Abstract] [Full Text] [Related]

  • 28. Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
    Xiong Y, Zhang Q, Ye J, Pan S, Ge L.
    PLoS One; 2018 Nov 28; 13(11):e0206853. PubMed ID: 30408066
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.
    Wang R, Hu X, Zhou Y, Feng Q, Su L, Long J, Wei B.
    Leuk Lymphoma; 2013 Jan 28; 54(1):153-9. PubMed ID: 22712837
    [Abstract] [Full Text] [Related]

  • 31. Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis.
    Zhang N, Ouyang Y, Chang J, Liu P, Tian X, Yu J.
    Biomed Res Int; 2020 Jan 28; 2020():3520764. PubMed ID: 33150172
    [Abstract] [Full Text] [Related]

  • 32. Association of XRCC1 genetic polymorphism (Arg399Gln) with laryngeal cancer: a meta-analysis based on 4,031 subjects.
    Chen W, Wang ZY, Xu FL, Wu KM, Zhang Y, Xu L, Wang QP.
    Tumour Biol; 2014 Feb 28; 35(2):1637-40. PubMed ID: 24194393
    [Abstract] [Full Text] [Related]

  • 33. Association between XRCC1 Arg280His polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis.
    Xu W, Liu SA, Li L, Shen ZY, Wu YL.
    Genet Mol Res; 2015 Jun 29; 14(2):7122-9. PubMed ID: 26125922
    [Abstract] [Full Text] [Related]

  • 34. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
    Lv MQ, Wang J, Yu XQ, Hong HH, Ren WJ, Ge P, Zhou DX.
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov 29; 218():12-20. PubMed ID: 28926725
    [Abstract] [Full Text] [Related]

  • 35. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
    Ma WQ, Han XQ, Wang X, Wang Y, Zhu Y, Liu NF.
    PLoS One; 2016 Nov 29; 11(11):e0166961. PubMed ID: 27870881
    [Abstract] [Full Text] [Related]

  • 36. Polymorphisms of DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln), and the risk of age-related cataract: a meta-analysis.
    Liu XC, Liu XF, Hu ZD, Li ZH.
    Curr Eye Res; 2015 Jul 29; 40(7):676-82. PubMed ID: 25285569
    [Abstract] [Full Text] [Related]

  • 37. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
    Yang HY, Yang SY, Shao FY, Wang HY, Wang YD.
    Asian Pac J Cancer Prev; 2015 Jul 29; 16(2):495-500. PubMed ID: 25684477
    [Abstract] [Full Text] [Related]

  • 38. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
    Wei B, Zhou Y, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, Hu Q, Wang Q, Wang Z, Yan Z.
    Prostate Cancer Prostatic Dis; 2011 Sep 29; 14(3):225-31. PubMed ID: 21647176
    [Abstract] [Full Text] [Related]

  • 39. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M, Zhou X, Ding X, Wei L, Zhao Y, Zhu T, Shi X, Qin D.
    Rheumatol Int; 2017 Mar 29; 37(3):435-444. PubMed ID: 27812739
    [Abstract] [Full Text] [Related]

  • 40. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
    Huang Y, Xie D, Tang N, Wang J, Zeng X, Zhao P, He L.
    Tumour Biol; 2014 Jan 29; 35(1):799-808. PubMed ID: 23990457
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.